NASDAQ : NYXH
Nyxoah SA — Key statistics
Healthcare · Medical Instruments & Supplies · Belgium
Last price 0.8715 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 88.27M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 90.56M |
| Enterprise Value | 48.22M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 100.07M |
| Shares Outstanding | 100.07M |
| Shares Change (YoY) | +21.45% |
| Shares Change (QoQ) | +31.87% |
| Owned by Insiders (%) | 26.26% |
| Owned by Institutions (%) | 12.62% |
| Float | 50.88M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.62 |
| Forward PS | 1.57 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.38 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.59 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -122.68% |
| Return on Assets (ROA) | -36.87% |
| Return on Invested Capital (ROIC) | -43.97% |
| Return on Capital Employed (ROCE) | -69.34% |
| Weighted Average Cost of Capital (WACC) | 7.48% |
| Revenue Per Employee | $161,023 |
| Profits Per Employee | -$713,606 |
| Employee Count | 154 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.91 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.68M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -83.04% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 29.91 |
| Average Volume (20 Days) | 235,683 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 213,619 |
| Short Previous Month | 322,282 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.42% |
| Short Ratio (days to cover) | 1.36 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 24.75M |
| Gross Profit | 14.90M |
| Operating Income | -96.02M |
| Pretax Income | -108.00M |
| Net Income | -109.68M |
| EBITDA | -94.53M |
| EBIT | -96.02M |
| Loss Per Share | -$2.42 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 111.72M |
| Total Debt | 68.53M |
| Net Cash | 43.18M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 94.95M |
| Book Value Per Share | 0.95 |
| Working Capital | 74.73M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -80.51M |
| Capital Expenditures | -2.30M |
| Depreciation & Amortization | 1.46M |
| Net Borrowing | 39.10M |
| Free Cash Flow | -82.81M |
| FCF Per Share | -$0.83 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.19% |
| Operating Margin | -387.96% |
| Pretax Margin | -436.37% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.45% |
| Shareholder Yield | -21.45% |
| Earnings Yield | -274.94% |
| FCF Yield | -92.35% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $2.78 |
| Price Target Difference | 215.99% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 121.51% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.8 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |